Latest Close
$10.83
Stock Hub
PLRZ
Polyrizon Ltd.
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients. Use the sections below to move between chart, technical analysis, fundamentals, and news.
1y Change
-$563.67 (-98.11%)
Market Cap
$17,568,026.00
Sector
Healthcare
Industry
Biotechnology
Recommendation
none
52W Range
$2.88 to $2,235.00
Target Mean Price
Not available
Beta
Not available
Trailing P/E
Not available
Forward P/E
Not available
Price / Book
0.83
Company Overview
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients. It also develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza blockers. Polyrizon Ltd. was incorporated in 2005 is headquartered in Ra'anana, Israel.